How many people with type 2 diabetes fulfil the eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real‐world setting?

Randomized controlled trial (RCT) populations often do not reflect those typically seen in clinical practice. This retrospective, observational cohort study analysed the real‐world data of people with type 2 diabetes (T2DM) prescribed basal insulin analogues from electronic medical records (EMRs) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauricio, Dídac, Westerbacka, Jukka, Nicholls, Charlie, Wu, Jasmanda, Gupta, Rishab, Eliasson, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898683/
https://www.ncbi.nlm.nih.gov/pubmed/33236461
http://dx.doi.org/10.1111/dom.14264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898683/
https://www.ncbi.nlm.nih.gov/pubmed/33236461
http://dx.doi.org/10.1111/dom.14264

Ejemplares similares